956111-97-0

Upstream product

• 2104-89-4 Ser-OMe 
• 23680-31-1 BOC-O-benzyl-L-serine 

Downstream Products

• 956111-98-1 C₁₉H₂₆N₂O₆ 
• 301661-90-5 2-((S)-1-Amino-2-benzyloxy-ethyl)-oxazole-4-carboxylic acid methyl ester 
• 1111629-70-9 C₂₇H₃₃N₅O₁₀ 
• 1111629-64-1 C₂₉H₃₅N₅O₉ 
• 1111629-72-1 C₂₇H₂₉N₅O₉ 
• 956111-88-9 C₃₈H₅₇N₅O₁₀Si 
• 956111-89-0 C₂₉H₃₇N₅O₁₀ 
• 956111-91-4 C₂₉H₃₃N₅O₉ 
• 956111-99-2 2-((S)-2-benzyloxy-1-tert-butoxycarbonylaminoethyl)oxazole-4-carboxylic acid methyl ester 

Relevant academic research and scientific papers

THERAPEUTIC COMPOUNDS

The invention provides compounds of formula (I) wherein A, B, R1, F, G, n, n' and the dotted line have any values defined herein, as well as salts thereof. The compounds have activity as anti-proliferative agents.

THERAPEUTIC COMPOUNDS

The invention provides compounds of formula I: wherein A, B, D, E, R1, R2, R3, R4, R5, X, and ----- have any values defined herein, as well as salts thereof. The compounds have activity as G-quadruplex DNA stabalizers and as anti-proliferative agents.